Cyril Amarchand Mangaldas Advised Tatvartha Health On ₹75 Cr Investment By Xponentia Opportunities Fund II
Cyril Amarchand Mangaldas Advised Tatvartha Health On ₹75 Cr Investment By Xponentia Opportunities Fund II
Cyril Amarchand Mangaldas (CAM) advised Tatvartha Health Private Limited (Traya) and its Promoters on Series B CCPS investment by Xponentia Opportunities Fund II for a stake of 6.68% in Traya, amounting to approximately INR 75 crores.
The transaction team at CAM was led by Dhruv Singhal, Partner, with support from Aparna Menon, Senior Associate; Hina Tolani, Associate; Shivangini Singh, Associate; Bhavya Arya, Associate; and Rushil Mehta, Associate.
Other parties to the transaction include: Fireside Ventures Investment Fund – II, Whiteboard Capital Fund – I, and Beacon Trusteeship Limited – Kae Capital Fund III (acted as existing investors).
The transaction documents were signed on 27th March 2024, with closing completed on 28th March 2024.
